| Literature DB >> 20728952 |
Anca-L Grosu1, Wolfgang A Weber.
Abstract
AA-PET (MET-PET and FET-PET) can be used for gross tumour volume (GTV) delineation in brain gliomas and for the differentiation between treatment-related changes (pseudo-progression, pseudo-regression) and residual/recurrent tumour. There are some data showing that MET-PET and (DOTATOC)-PET can be used for GTV delineation in meningiomas and glomus tumours. The role of PET in the visualization of the biological characteristics of the tumours: proliferation (FLT-PET), hypoxia (FMISO-PET) and angiogenesis/peptide expression (RGD-PET) should be investigated in future studies. Copyright 2010 European Society for Therapeutic Radiology and Oncology and European Association of Nuclear Medicine. Published by Elsevier Ireland Ltd.. All rights reserved.Entities:
Mesh:
Year: 2010 PMID: 20728952 DOI: 10.1016/j.radonc.2010.08.001
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280